Replicate Bioscience is pioneering novel self-replicating RNA (srRNA) technology to enable more treatment opportunities for more people.
Nathaniel Wang · Executive Officer, Director · decision-maker
Michael Ehlers · Executive Officer, Director · decision-maker
Joseph Yanchik · Director
Seth Harrison · Director
Careers mailbox is known
Feb 4, 2021
Raised a round Venture round $20M · SEC Form D
2021
Founded
Accelerating the development of better drugs for better targets in a quest to alter the trajectory of neurodegenerative disease.
No named decision-maker yet.
Careers mailbox is known
Sep 27
Moved to Greenhouse
Galvanize Therapeutics designs pulsed electric field energy devices for the surgical ablation of soft tissue, engineered to work with the body's biology.
No named decision-maker yet.
Careers mailbox is known
Sep 28
Senior Service Engineer crossed 90 days open
Sep 25
Posted 9 roles Sr. Manager FP&A, Commercial & Operations, Sr. FP&A Manager, Corporate Finance
9 open
$167k stated pay, 7 roles
Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated steatohepatitis (MASH).
No named decision-maker yet.
No careers mailbox known
Sep 27
Moved to Greenhouse